Share Price and Basic Stock Data
Last Updated: January 28, 2026, 11:23 am
| PEG Ratio | 1.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ARCL Organics Ltd operates in the chemicals sector, focusing on organic products. The company reported a market capitalization of ₹211 Cr and a current share price of ₹263. Over the past fiscal years, ARCL has demonstrated a robust revenue trajectory, with sales rising from ₹49 Cr in March 2018 to ₹165 Cr in March 2023, and standing at ₹288 Cr for the trailing twelve months (TTM). The revenue growth is evident in the quarterly sales figures, which ranged from ₹31.71 Cr in December 2022 to ₹61.96 Cr in December 2024. The company has maintained a steady upward trend, reflecting a strong demand for its products. The operating profit margin (OPM) for the TTM stood at 13.21%, indicating effective cost management relative to its sales. Overall, the continuous growth in revenue and the solid market presence position ARCL well against peers within the organic chemicals segment.
Profitability and Efficiency Metrics
ARCL Organics has reported a net profit of ₹18 Cr for the TTM, translating to a net profit margin of 4.92%. This performance, while modest compared to industry leaders, reflects consistent profitability in a competitive market. The company recorded a return on equity (ROE) of 16.8% and a return on capital employed (ROCE) of 20.4%, both metrics indicating efficient use of shareholder funds and capital. The interest coverage ratio (ICR) stood at 6.23x, showing the company’s ability to meet interest obligations comfortably. However, the operating profit margin (OPM) has shown fluctuations, hitting a low of 4.26% in December 2022 before recovering to 13.21% in the TTM. The cash conversion cycle (CCC) was reported at 28 days, suggesting efficient management of working capital, although a longer CCC could pose risks in liquidity during downturns.
Balance Sheet Strength and Financial Ratios
ARCL’s balance sheet reflects a growing financial strength with total assets reported at ₹176 Cr as of September 2025. The company has maintained a conservative approach towards debt, with borrowings reported at ₹42 Cr, resulting in a total debt-to-equity ratio of 0.43. This is relatively low compared to typical industry standards, which enhances financial stability. Reserves have grown to ₹78 Cr, indicating a solid buffer for future investments and potential downturns. The book value per share has risen to ₹96.81, demonstrating an increase in shareholder value over time. With a price-to-book value (P/BV) ratio of 2.37x, ARCL is priced at a premium compared to its book value, which is typical in growth-oriented companies. Overall, the company’s balance sheet appears robust, providing a solid foundation for future growth.
Shareholding Pattern and Investor Confidence
ARCL Organics Ltd has a stable shareholding structure, with promoters holding a significant 69.22% stake as of September 2023. This high level of promoter ownership typically indicates strong confidence in the company’s future, aligning interests with minority shareholders. Institutional investment is minimal, with domestic institutional investors (DIIs) holding 0.75% of the shares, while foreign institutional investors (FIIs) have no reported stake. The public holds 30.03%, reflecting a diverse but concentrated ownership. The number of shareholders has increased from 6,663 in September 2023 to 7,929 by September 2025, suggesting growing interest and confidence among retail investors. This positive trend in shareholder numbers may enhance liquidity and market perception, which is crucial for the company’s long-term stability.
Outlook, Risks, and Final Insight
Looking ahead, ARCL Organics is well-positioned to capitalize on the growing demand for organic chemicals, supported by its strong revenue trajectory and efficient operations. However, risks remain, including fluctuations in raw material costs and potential regulatory challenges in the chemicals sector. The company’s relatively low institutional ownership may also limit its visibility among larger investors. Continued investment in product innovation and market expansion will be critical for sustaining growth. While the company has shown resilience and profitability, it must navigate these risks effectively to maintain its upward momentum. If ARCL can enhance its operational efficiency and manage costs, it may achieve stronger margins and further investor confidence, leading to potential market re-rating in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 58.9 Cr. | 165 | 437/135 | 137 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,020 Cr. | 8,855 | 14,250/8,150 | 50.8 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 27.0 Cr. | 90.0 | 329/84.1 | 13.4 | 26.9 | 1.11 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 205 Cr. | 257 | 435/163 | 11.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,481.50 Cr | 1,439.07 | 56.19 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.00 | 31.71 | 46.44 | 41.58 | 43.25 | 48.33 | 57.57 | 59.93 | 56.46 | 61.96 | 72.24 | 67.34 | 86.19 |
| Expenses | 36.27 | 30.36 | 40.04 | 38.47 | 39.51 | 41.00 | 52.20 | 54.12 | 51.33 | 58.14 | 63.25 | 60.94 | 74.80 |
| Operating Profit | 4.73 | 1.35 | 6.40 | 3.11 | 3.74 | 7.33 | 5.37 | 5.81 | 5.13 | 3.82 | 8.99 | 6.40 | 11.39 |
| OPM % | 11.54% | 4.26% | 13.78% | 7.48% | 8.65% | 15.17% | 9.33% | 9.69% | 9.09% | 6.17% | 12.44% | 9.50% | 13.21% |
| Other Income | 0.58 | 0.01 | 2.25 | 0.43 | 0.64 | 0.81 | 0.82 | 0.41 | 0.71 | 0.83 | 0.40 | 0.83 | 1.18 |
| Interest | 0.44 | 0.45 | 0.51 | 0.51 | 1.03 | 1.85 | 0.76 | 1.25 | 1.23 | 1.14 | 1.24 | 1.17 | 0.99 |
| Depreciation | 1.00 | 0.64 | 1.30 | 1.33 | 1.29 | 1.17 | 0.50 | 1.37 | 1.13 | 1.29 | 1.42 | 1.39 | 1.49 |
| Profit before tax | 3.87 | 0.27 | 6.84 | 1.70 | 2.06 | 5.12 | 4.93 | 3.60 | 3.48 | 2.22 | 6.73 | 4.67 | 10.09 |
| Tax % | 28.94% | 29.63% | 73.39% | 16.47% | 55.83% | 30.86% | 2.03% | 27.22% | 42.53% | 24.77% | 19.02% | 18.42% | 29.83% |
| Net Profit | 2.76 | 0.19 | 1.81 | 1.42 | 0.91 | 3.53 | 4.83 | 2.62 | 2.01 | 1.67 | 5.46 | 3.81 | 7.08 |
| EPS in Rs | 3.45 | 0.24 | 2.26 | 1.78 | 1.14 | 4.41 | 6.04 | 3.28 | 2.51 | 2.09 | 6.82 | 4.76 | 8.85 |
Last Updated: December 28, 2025, 2:34 am
Below is a detailed analysis of the quarterly data for ARCL Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 86.19 Cr.. The value appears strong and on an upward trend. It has increased from 67.34 Cr. (Jun 2025) to 86.19 Cr., marking an increase of 18.85 Cr..
- For Expenses, as of Sep 2025, the value is 74.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 60.94 Cr. (Jun 2025) to 74.80 Cr., marking an increase of 13.86 Cr..
- For Operating Profit, as of Sep 2025, the value is 11.39 Cr.. The value appears strong and on an upward trend. It has increased from 6.40 Cr. (Jun 2025) to 11.39 Cr., marking an increase of 4.99 Cr..
- For OPM %, as of Sep 2025, the value is 13.21%. The value appears strong and on an upward trend. It has increased from 9.50% (Jun 2025) to 13.21%, marking an increase of 3.71%.
- For Other Income, as of Sep 2025, the value is 1.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.83 Cr. (Jun 2025) to 1.18 Cr., marking an increase of 0.35 Cr..
- For Interest, as of Sep 2025, the value is 0.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.17 Cr. (Jun 2025) to 0.99 Cr., marking a decrease of 0.18 Cr..
- For Depreciation, as of Sep 2025, the value is 1.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.39 Cr. (Jun 2025) to 1.49 Cr., marking an increase of 0.10 Cr..
- For Profit before tax, as of Sep 2025, the value is 10.09 Cr.. The value appears strong and on an upward trend. It has increased from 4.67 Cr. (Jun 2025) to 10.09 Cr., marking an increase of 5.42 Cr..
- For Tax %, as of Sep 2025, the value is 29.83%. The value appears to be increasing, which may not be favorable. It has increased from 18.42% (Jun 2025) to 29.83%, marking an increase of 11.41%.
- For Net Profit, as of Sep 2025, the value is 7.08 Cr.. The value appears strong and on an upward trend. It has increased from 3.81 Cr. (Jun 2025) to 7.08 Cr., marking an increase of 3.27 Cr..
- For EPS in Rs, as of Sep 2025, the value is 8.85. The value appears strong and on an upward trend. It has increased from 4.76 (Jun 2025) to 8.85, marking an increase of 4.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:12 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 71 | 71 | 87 | 141 | 165 | 191 | 251 | 288 |
| Expenses | 46 | 67 | 64 | 74 | 126 | 147 | 171 | 227 | 257 |
| Operating Profit | 2 | 4 | 7 | 12 | 15 | 18 | 20 | 24 | 31 |
| OPM % | 5% | 6% | 10% | 14% | 11% | 11% | 10% | 9% | 11% |
| Other Income | 2 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 3 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 5 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 5 | 6 |
| Profit before tax | 1 | 2 | 3 | 10 | 15 | 17 | 14 | 16 | 24 |
| Tax % | 45% | 26% | 24% | 29% | 29% | 30% | 23% | 27% | |
| Net Profit | 1 | 1 | 3 | 7 | 10 | 12 | 11 | 12 | 18 |
| EPS in Rs | 0.70 | 1.40 | 3.21 | 9.14 | 13.10 | 14.72 | 13.38 | 14.69 | 22.52 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 200.00% | 133.33% | 42.86% | 20.00% | -8.33% | 9.09% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | -66.67% | -90.48% | -22.86% | -28.33% | 17.42% |
ARCL Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 10, 2025, 3:50 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 13 | 14 | 16 | 24 | 34 | 46 | 56 | 68 | 78 |
| Borrowings | 10 | 20 | 17 | 10 | 16 | 20 | 29 | 35 | 42 |
| Other Liabilities | 18 | 15 | 13 | 26 | 35 | 39 | 55 | 50 | 48 |
| Total Liabilities | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 | 176 |
| Fixed Assets | 18 | 21 | 20 | 20 | 26 | 45 | 62 | 67 | 70 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 30 | 35 | 33 | 47 | 66 | 66 | 85 | 93 | 105 |
| Total Assets | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 | 176 |
Below is a detailed analysis of the balance sheet data for ARCL Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 78.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 35.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48.00 Cr.. The value appears to be improving (decreasing). It has decreased from 50.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 15.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 12.00 Cr..
- For Total Assets, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 161.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 15.00 Cr..
Notably, the Reserves (78.00 Cr.) exceed the Borrowings (42.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -16.00 | -10.00 | 2.00 | -1.00 | -2.00 | -9.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 87 | 87 | 96 | 82 | 71 | 65 | 75 |
| Inventory Days | 59 | 35 | 45 | 40 | 43 | 38 | 58 | 28 |
| Days Payable | 102 | 51 | 43 | 89 | 88 | 83 | 110 | 75 |
| Cash Conversion Cycle | 55 | 71 | 89 | 48 | 37 | 25 | 13 | 28 |
| Working Capital Days | 56 | 84 | 32 | 49 | 46 | 31 | 25 | 28 |
| ROCE % | 9% | 15% | 30% | 33% | 28% | 21% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Diluted EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Cash EPS (Rs.) | 21.93 | 19.49 | 17.93 | 14.95 | 11.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Revenue From Operations / Share (Rs.) | 313.24 | 238.40 | 206.32 | 176.58 | 108.34 |
| PBDIT / Share (Rs.) | 32.70 | 27.52 | 26.63 | 22.04 | 18.27 |
| PBIT / Share (Rs.) | 26.19 | 22.15 | 23.30 | 20.25 | 16.42 |
| PBT / Share (Rs.) | 20.94 | 18.31 | 20.87 | 18.56 | 14.03 |
| Net Profit / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| NP After MI And SOA / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| PBDIT Margin (%) | 10.43 | 11.54 | 12.90 | 12.48 | 16.86 |
| PBIT Margin (%) | 8.36 | 9.29 | 11.29 | 11.46 | 15.15 |
| PBT Margin (%) | 6.68 | 7.68 | 10.11 | 10.50 | 12.95 |
| Net Profit Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| NP After MI And SOA Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| Return on Networth / Equity (%) | 15.92 | 17.25 | 21.51 | 24.75 | 24.97 |
| Return on Capital Employeed (%) | 20.80 | 19.94 | 26.46 | 31.05 | 32.01 |
| Return On Assets (%) | 7.30 | 7.18 | 9.70 | 11.13 | 12.83 |
| Long Term Debt / Equity (X) | 0.20 | 0.27 | 0.19 | 0.08 | 0.06 |
| Total Debt / Equity (X) | 0.43 | 0.44 | 0.37 | 0.33 | 0.26 |
| Asset Turnover Ratio (%) | 1.54 | 1.37 | 1.54 | 0.00 | 1.48 |
| Current Ratio (X) | 1.48 | 1.37 | 1.47 | 1.59 | 1.94 |
| Quick Ratio (X) | 1.27 | 1.04 | 1.22 | 1.30 | 1.65 |
| Inventory Turnover Ratio (X) | 13.80 | 7.98 | 9.77 | 0.00 | 9.59 |
| Interest Coverage Ratio (X) | 6.23 | 7.17 | 10.99 | 13.03 | 7.66 |
| Interest Coverage Ratio (Post Tax) (X) | 3.94 | 4.68 | 7.02 | 8.78 | 5.21 |
| Enterprise Value (Cr.) | 198.81 | 48.46 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 0.79 | 0.25 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 7.60 | 2.20 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.37 | 0.52 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.06 | 0.32 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for ARCL Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 21.93. This value is within the healthy range. It has increased from 19.49 (Mar 24) to 21.93, marking an increase of 2.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 313.24. It has increased from 238.40 (Mar 24) to 313.24, marking an increase of 74.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 27.52 (Mar 24) to 32.70, marking an increase of 5.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.19. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 26.19, marking an increase of 4.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 20.94. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 20.94, marking an increase of 2.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For PBDIT Margin (%), as of Mar 25, the value is 10.43. This value is within the healthy range. It has decreased from 11.54 (Mar 24) to 10.43, marking a decrease of 1.11.
- For PBIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 9.29 (Mar 24) to 8.36, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 6.68, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 5. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 15.92, marking a decrease of 1.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.80. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 20.80, marking an increase of 0.86.
- For Return On Assets (%), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.30, marking an increase of 0.12.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.20, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.44 (Mar 24) to 0.43, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has increased from 1.37 (Mar 24) to 1.54, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.48, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.27, marking an increase of 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.80. This value exceeds the healthy maximum of 8. It has increased from 7.98 (Mar 24) to 13.80, marking an increase of 5.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has decreased from 7.17 (Mar 24) to 6.23, marking a decrease of 0.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.94. This value is within the healthy range. It has decreased from 4.68 (Mar 24) to 3.94, marking a decrease of 0.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 198.81. It has increased from 48.46 (Mar 24) to 198.81, marking an increase of 150.35.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.79, marking an increase of 0.54.
- For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 7.60, marking an increase of 5.40.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For Price / BV (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 2.37, marking an increase of 1.85.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.32 (Mar 24) to 0.06, marking a decrease of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ARCL Organics Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.8% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.92% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.4 (Industry average Stock P/E: 56.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Rampur, P.S. Maheshtala, Budge Budge Trunk Road, Kolkata West Bengal 700141 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Suraj Ratan Mundhra | Chairman & Managing Director |
| Mr. Rajesh Mundhra | Executive Director |
| Mr. Brij Mohan Mohta | Ind. Non-Executive Director |
| Mrs. Stuti Pithisaria | Ind. Non-Executive Director |
| Mr. Prateek Chaudhary | Ind. Non-Executive Director |
| Mr. Mukesh Mundra | Executive Director |
FAQ
What is the intrinsic value of ARCL Organics Ltd?
ARCL Organics Ltd's intrinsic value (as of 28 January 2026) is ₹188.10 which is 26.81% lower the current market price of ₹257.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹205 Cr. market cap, FY2025-2026 high/low of ₹435/163, reserves of ₹78 Cr, and liabilities of ₹176 Cr.
What is the Market Cap of ARCL Organics Ltd?
The Market Cap of ARCL Organics Ltd is 205 Cr..
What is the current Stock Price of ARCL Organics Ltd as on 28 January 2026?
The current stock price of ARCL Organics Ltd as on 28 January 2026 is ₹257.
What is the High / Low of ARCL Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ARCL Organics Ltd stocks is ₹435/163.
What is the Stock P/E of ARCL Organics Ltd?
The Stock P/E of ARCL Organics Ltd is 11.4.
What is the Book Value of ARCL Organics Ltd?
The Book Value of ARCL Organics Ltd is 108.
What is the Dividend Yield of ARCL Organics Ltd?
The Dividend Yield of ARCL Organics Ltd is 0.00 %.
What is the ROCE of ARCL Organics Ltd?
The ROCE of ARCL Organics Ltd is 20.4 %.
What is the ROE of ARCL Organics Ltd?
The ROE of ARCL Organics Ltd is 16.8 %.
What is the Face Value of ARCL Organics Ltd?
The Face Value of ARCL Organics Ltd is 10.0.